Long-term stability of recombinant tissue plasminogen activator at -80 C

Article English OPEN
Shaw, George J ; Sperling, Matthew ; Meunier, Jason M (2009)
  • Publisher: Springer Nature
  • Journal: BMC Research Notes, volume 2, pages 117-117 (issn: 1756-0500, eissn: 1756-0500)
  • Related identifiers: doi: 10.1186/1756-0500-2-117, pmc: PMC2711093
  • Subject: R | Biochemistry, Genetics and Molecular Biology(all) | Medicine(all) | Medicine | Technical Note | Biology (General) | QH301-705.5
    mesheuropmc: integumentary system

<p>Abstract</p> <p>Background</p> <p>Recombinant tissue plasminogen activator (tPA) is a thrombolytic widely used clinically in the treatment of acute thrombotic disease such as ischemic stroke, myocardial infarction, and deep venous thrombosis. This has led to much int... View more
  • References (5)

    Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, et al.: Guidelines for Thrombolytic Therapy for Acute Stroke: a Supplement to the Guidelines for the Management of Patients with Acute Ischemic Stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 1996, 27(9):1711-1718.

    Pancioli AM, Brott TG: Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute ischaemic stroke: scientific rationale and available evidence. CNS drugs 2004, 18(14):981-988.

    Loren M, Fade-Garcia LJ, Toorado MC, Navarro JL: Thrombus age and tissue plasminogen activator mediated thrombolysis in rats. Thrombosis Research 1989, 56:67-76.

    Jaffe GJ, Green GD, Abrams GH: Stability of recombinant tissue plasminogen activator. American Journal of Ophthalmology 1989, 108(1):90-91.

    Wiernikowski JT, Crowther M, Clase CM, Ingram A, Andrew M, Chan AK: Stability and sterility of recombinant tissue plasminogen activator at -30 degrees C. Lancet 2000, 355(9222):2221-2222.

  • Metrics
    No metrics available
Share - Bookmark